EP3600433
AN AGENT THAT INCREASES THE EXPRESSSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.3.2018EP published:
5.5.2021EP application number:
18717108.7
EPO information:
European Patent Register
Max expiry date:
27.3.2038
Title:
AN AGENT THAT INCREASES THE EXPRESSSION OF THE BCL2-ASSOCIATED AGONIST OF CELL DEATH FOR THE TREATMENT OF CANCER
Timeline
Today
28.3.2018EP application
5.5.2021EP Publication
Owner
Name:
LDN Pharma LimitedAddress:
25 Moorgate, London, EC2R 6AY, GB
Inventor
Name:
DALGLEISH, AngusAddress:
London Greater London EC1M 3AB, GB
Name:
LUI, WaiAddress:
London Greater London EC1M 3AB, GB
Priority
Number:
201704910Date:
28.3.2017Country:
GB
Number:
201718806Date:
14.11.2017Country:
GB
Classification
Categories:
A61K 31/485, A61K 31/555, A61K 31/675, A61K 31/7068, A61K 45/06, A61P 35/00, G01N 33/50